GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
109.12
+3.99 (3.80%)
Aug 11, 2025, 11:05 AM - Market open
Paramount Global Market Cap
GeneDx Holdings has a market cap or net worth of $3.13 billion as of August 11, 2025. Its market cap has increased by 254.21% in one year.
Market Cap
3.13B
Enterprise Value
3.07B
1-Year Change
254.21%
Ranking
Category
Stock Price
$109.12
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.13B, a decrease of -82.49%. That is a compound annual growth rate of -30.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.02B | 43.03% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | 17.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |